- Home
- CDTX vs RLX Comparison
CDTX vs RLX Comparison
Compare CDTX & RLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CDTX | RLX |
|---|---|---|
| Founded | 2012 | 2018 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.0B |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CDTX | RLX |
|---|---|---|
| Price | $220.50 | $2.36 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 1 |
| Target Price | ★ $128.75 | $2.25 |
| AVG Volume (30 Days) | ★ 2.3M | 2.0M |
| Earning Date | 11-06-2025 | 11-14-2025 |
| Dividend Yield | N/A | ★ 4.66% |
| EPS Growth | N/A | ★ 19.33 |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | ★ $459,694,770.00 |
| Revenue This Year | N/A | $63.02 |
| Revenue Next Year | N/A | $24.72 |
| P/E Ratio | ★ N/A | $28.46 |
| Revenue Growth | N/A | ★ 51.58 |
| 52 Week Low | $15.22 | $1.66 |
| 52 Week High | $221.20 | $2.84 |
Technical Indicators
Market Signals| Indicator | CDTX | RLX |
|---|---|---|
| Relative Strength Index (RSI) | 86.62 | 44.69 |
| Support Level | $219.60 | $2.34 |
| Resistance Level | $220.38 | $2.47 |
| Average True Range (ATR) | 0.74 | 0.06 |
| MACD | -3.92 | -0.01 |
| Stochastic Oscillator | 67.82 | 11.63 |
Price Performance
Historical ComparisonAbout CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About RLX RLX Technology Inc. each representing the right to receive one (1) ordinary share
RLX Technology Inc is engaged in the manufacturing of e-vapor products for adult smokers. It has an integrated offline distribution and "Branded store plus" retail model tailored to China's e-vapor market.